Hepatic Impairment
3 competing products in clinical development for Hepatic Impairment.
Pipeline by Phase
Phase 12
Phase 1/21
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| GB1211 + Placebo | Comac Medical | Phase 1/2 | UNKNOWN | 33 |
| ACT-541468 25 mg + ACT-541468 25 mg (or 10 mg depending on interim results) | Idorsia | Phase 1 | Completed | 28 |
| ITF2357 | Biotrial | Phase 1 | Completed | 25 |